AMYRIS, INC.
Engineered microorganisms that produce high-performance molecules through fermentation-based biomanufacturing
- Sector
- Biotech
- Headquarters
- EMERYVILLE, CA
- Latest Form D
- $8M, Sep 2022
- Total capital
- $1.6B
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $1.6B
- 49 Form D · last Sep 2022
- 49 months since last filing
- Federal contracts
- $303K
- 4 awards · NASA, Defense
- Rank in Biotech#262 of 4373
- Granted patents
- 18
- 22 pending · first 2024
- Rank in peer group#22 of 1449
Capital timeline
Latest events
- Federal contractDefense · Biosynthetic Caryopholen$254K
- Private capital raisedForm D · SEC · 49th filing$8M
- Private capital raisedForm D · SEC · 48th filing$200M
- Private capital raisedForm D · SEC · 47th filing$93.7M
- Private capital raisedForm D · SEC · 46th filing$9.8M
- Private capital raisedForm D · SEC · 45th filing$3.9M
- Private capital raisedForm D · SEC · 44th filing$7.8M
- Private capital raisedForm D · SEC · 43rd filing$7.7M
- Private capital raisedForm D · SEC · 42nd filing$5.7M
- Private capital raisedForm D · SEC · 41st filing$12.5M
- Private capital raisedForm D · SEC · 40th filing$19M
- Private capital raisedForm D · SEC · 39th filing$9.9M
- Private capital raisedForm D · SEC · 38th filing$74.7M
- Private capital raisedForm D · SEC · 37th filing$35.6M
- Private capital raisedForm D · SEC · 36th filing$60M
- Private capital raisedForm D · SEC · 35th filing$7.3M
- Private capital raisedForm D · SEC · 34th filing$91M
- Private capital raisedForm D · SEC · 33rd filing$38.1M
- Private capital raisedForm D · SEC · 32nd filing$25M
- Private capital raisedForm D · SEC · 31st filing$25M
- Private capital raisedForm D · SEC · 30th filing$5.7M
- Private capital raisedForm D · SEC · 29th filing$65.2M
- Private capital raisedForm D · SEC · 28th filing$19.1M
- Private capital raisedForm D · SEC · 27th filing$25M
- Private capital raisedForm D · SEC · 26th filing$5.7M
- Private capital raisedForm D · SEC · 25th filing$8.5M
- Private capital raisedForm D · SEC · 24th filing$6M
- Private capital raisedForm D · SEC · 23rd filing$2.9M
- Private capital raisedForm D · SEC · 22nd filing$5M
- Private capital raisedForm D · SEC · 21st filing$5M
- Private capital raisedForm D · SEC · 20th filing$20M
- Private capital raisedForm D · SEC · 19th filing$57.6M
- Private capital raisedForm D · SEC · 18th filing$25M
- Private capital raisedForm D · SEC · 17th filing$141M
- Private capital raisedForm D · SEC · 16th filing$10.8M
- Private capital raisedForm D · SEC · 15th filing$4M
- Private capital raisedForm D · SEC · 14th filing$51.8M
- Private capital raisedForm D · SEC · 13th filing$10M
- Private capital raisedForm D · SEC · 12th filing$5M
- Private capital raisedForm D · SEC · 11th filing$42.2M
- Private capital raisedForm D · SEC · 10th filing$38.3M
- Private capital raisedForm D · SEC · 9th filing$4.1M
- Private capital raisedForm D · SEC · 8th filing$58.7M
- Private capital raisedForm D · SEC · 7th filing$25M
- Private capital raisedForm D · SEC · 6th filing$7M
- Private capital raisedForm D · SEC · 5th filing$13.8M
- Private capital raisedForm D · SEC · 4th filing$133M
- Private capital raisedForm D · SEC · 3rd filing$47.8M
- Private capital raisedForm D · SEC · 2nd filing$2.4M
- Private capital raisedForm D · SEC · 1st filing$24.7M
Show 3 earlier federal awards
- Federal contractDefense · Igf::ot::igf - Wait, What Conference Purchase Order$16K
- Federal contractNASA · Amyris Aviation Grade Farnesane$8K
- Federal contractNASA · Synthetic Jet Fuel 500 Gallons$25K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#22 · top 2%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Abraham KlaeijsenDirectorNamed in SEC Form D filings
- ANA JOHN DUTRADirectorNamed in SEC Form D filings
- ARTHUR R. LEVINSONDirectorNamed in SEC Form D filings
- BRAM JOHN KLAEIJSENDirectorNamed in SEC Form D filings
- CAROLE R. PIWNICADirectorNamed in SEC Form D filings
- CHRISTOPHE VUILLEZDirectorNamed in SEC Form D filings
Show all 63 people
- CHRISTOPH JOHN GOPPELSROEDERDirectorNamed in SEC Form D filings
- EDUARDO ALVAREZExecutive OfficerNamed in SEC Form D filings
- Fernando de Castro ReinachDirectorNamed in SEC Form D filings
- FERNANDO R. REINACHDirectorNamed in SEC Form D filings
- FRANK JOHN KUNGDirectorNamed in SEC Form D filings
- GARY LOEBExecutive OfficerNamed in SEC Form D filings
- Geoff DuykDirectorNamed in SEC Form D filings
- GEOFFREY JOHN DUYKDirectorNamed in SEC Form D filings
- HAN JOHN KEIFTENBELDExecutive OfficerNamed in SEC Form D filings
- HERMANUS KIEFTENBELDExecutive OfficerNamed in SEC Form D filings
- HH SHEIK ABDULLAH BIN KHALIFA NEIL AL THANIDirectorNamed in SEC Form D filings
- HH SHEIKH ABDULLAH BIN KHALIFA NEIL AL THANIDirectorNamed in SEC Form D filings
- HH SHIEK ABDULLAH BIN KHALIFA NEIL AL THANIDirectorNamed in SEC Form D filings
- Jack NewmanExecutive OfficerNamed in SEC Form D filings
- JAMES NEIL MCCANNDirectorNamed in SEC Form D filings
- Jeff LievenseExecutive OfficerNamed in SEC Form D filings
- Jeryl HillemanExecutive OfficerNamed in SEC Form D filings
- JOEL CHERRYExecutive OfficerNamed in SEC Form D filings
- JOHN R. DOERRDirectorNamed in SEC Form D filings
- JOHN MELOExecutive Officer, DirectorNamed in SEC Form D filings
- JONATHAN NEIL WOLTERExecutive OfficerNamed in SEC Form D filings
- JULIE JOHN WASHINGTONDirectorNamed in SEC Form D filings
- KATHLEEN VALIASEKExecutive OfficerNamed in SEC Form D filings
- Kinkead ReilingExecutive Officer, DirectorNamed in SEC Form D filings
- L JOHN DOERRDirectorNamed in SEC Form D filings
- L. JOHN DOERRDirectorNamed in SEC Form D filings
- LISA NEIL QIDirectorNamed in SEC Form D filings
- MARGARET JOHN GEORGIADISDirectorNamed in SEC Form D filings
- MARGO JOHN GEORGIADISDirectorNamed in SEC Form D filings
- Mario PortelaExecutive OfficerNamed in SEC Form D filings
- Mark R. PatelExecutive OfficerNamed in SEC Form D filings
- NAM-HAI R. CHUADirectorNamed in SEC Form D filings
- NEIL R. RENNINGERDirectorNamed in SEC Form D filings
- NEIL WILLIAMSDirectorNamed in SEC Form D filings
- NICHOLAS KHADDERExecutive OfficerNamed in SEC Form D filings
- NICOLE KELSEYExecutive OfficerNamed in SEC Form D filings
- Patrick PichetteDirectorNamed in SEC Form D filings
- PATRICK NEIL YANGDirectorNamed in SEC Form D filings
- PAT NEIL YANGDirectorNamed in SEC Form D filings
- PAULO DINIZExecutive OfficerNamed in SEC Form D filings
- Peter BoyntonExecutive OfficerNamed in SEC Form D filings
- PHILIP JOHN EYKERMANDirectorNamed in SEC Form D filings
- PHILIPPE BOISSEAUDirectorNamed in SEC Form D filings
- Phillippe BoisseauDirectorNamed in SEC Form D filings
- PIWNICA JOHN CAROLEDirectorNamed in SEC Form D filings
- RAFFI ASADORIANExecutive OfficerNamed in SEC Form D filings
- Ralph AlexanderDirectorNamed in SEC Form D filings
- R NEIL WILLIAMSDirectorNamed in SEC Form D filings
- R. NEIL WILLIAMSDirectorNamed in SEC Form D filings
- RYAN JOHN PANCHADSARAMDirectorNamed in SEC Form D filings
- Samir KaulDirectorNamed in SEC Form D filings
- SHEIK ABDULLAH BIN KHALIFA AL THANIDirectorNamed in SEC Form D filings
- SHEIKH ABDULLAH BIN KHALIFA R. AL THANIDirectorNamed in SEC Form D filings
- STEVEN JOHN MILLSDirectorNamed in SEC Form D filings
- SUSANNA MCFERSONExecutive OfficerNamed in SEC Form D filings
- Tamara TompkinsExecutive OfficerNamed in SEC Form D filings
- YANG PATRICKDirectorNamed in SEC Form D filings
What it has protected
USPTO · 18 granted of 40- GrantedCulture Compositions And Methods Of Their Use For High Yield Production Of VanillinUSPTOUS 12,742,186
- GrantedAMORPHA-4,11-DIENE 12-MONOOXYGENASE Variants And Uses ThereofUSPTOUS 12,735,683
- PendingAbc Transporters For The High Efficiency Production Of RebaudiosidesUSPTOApplication 19420323
Show all 40 patent records
- Culture Compositions And Methods Of Their Use For High Yield Production Of VanillinSep 22, 2026 · US 12,742,186Granted
- AMORPHA-4,11-DIENE 12-MONOOXYGENASE Variants And Uses ThereofSep 15, 2026 · US 12,735,683Granted
- Abc Transporters For The High Efficiency Production Of RebaudiosidesSep 3, 2026 · Application 19420323Pending
- Production Of CanthaxanthinJul 30, 2026 · Application 19145846Pending
- Sugarcane Derived Semi-synthetic Cosmetic Ingredients, Methods Of Production Thereof, And Personal Care Products Derived TherefromJul 23, 2026 · Application 19157872Pending
- Maltose Dependent Degrons, Maltose-responsive Promoters, Stabilization Constructs, And Their Use In Production Of Non-catabolic CompoundsJul 23, 2026 · Application 19409319Pending
- Modified BETA-1,3-N-ACETYLGLUCOSAMINYLTRANSFERASE PolypeptidesJul 14, 2026 · US 12,680,086Granted
- Microbial Production Of CannabinoidsJun 25, 2026 · Application 19416289Pending
- Maltose Dependent Degrons, Maltose-responsive Promoters, Stabilization Constructs, And Their Use In Production Of Non-catabolic CompoundsMay 7, 2026 · Application 19297763Pending
- Compositions And Methods For Improved Cell Culture EfficiencyMar 12, 2026 · Application 18873143Pending
- Oligosaccharide Production In YeastMar 12, 2026 · Application 19234583Pending
- Kaurenoic Acid 13-HYDROXYLASE (kah) Variants And Uses ThereofMar 5, 2026 · Application 19254544Pending
- Abc Transporters For The High Efficiency Production Of RebaudiosidesJan 20, 2026 · US 12,529,087Granted
- Microbial Production Of CannabinoidsJan 13, 2026 · US 12,522,849Granted
- Modified Host Cells For High Efficiency Production Of VanillinJan 6, 2026 · US 12,516,357Granted
- Compositions And Methods For The Purification Of SqualeneDec 11, 2025 · Application 18876576Pending
- Compositions And Methods For The Purification Of IsoprenoidsDec 4, 2025 · Application 19234776Pending
- Modified Host Cells For High Efficiency Production Of VanillinNov 25, 2025 · US 12,480,101Granted
- Kaurenoic Acid 13-HYDROXYLASE (kah) Variants And Uses ThereofNov 11, 2025 · US 12,467,039Granted
- Improved Oligosaccharide Production In YeastNov 6, 2025 · Application 18869133Pending
- Pisum Sativum Kaurene Oxidase For High Efficiency Production Of RebaudiosidesOct 23, 2025 · Application 19096566Pending
- Compositions And Methods For Improved Production Of Human Milk OligosaccharidesSep 25, 2025 · Application 18722302Pending
- Maltose Dependent Degrons, Maltose-responsive Promoters, Stabilization Constructs, And Their Use In Production Of Non-catabolic CompoundsSep 2, 2025 · US 12,404,310Granted
- Stevia Rebaudiana Kaurenoic Acid Hydroxylase Variants For High Efficiency Production Of RebaudiosidesAug 14, 2025 · Application 19004028Pending
- Compositions And Methods For Production Of MyrceneJul 29, 2025 · US 12,371,696Granted
- Compositions And Methods For The Purification Of IsoprenoidsJul 15, 2025 · US 12,358,856Granted
- Improved Oligosaccharide Production In Yeast Cells Expressing An Abc Transporter ProteinJul 15, 2025 · US 12,359,234Granted
- HIGH pH METHODS AND COMPOSITIONS FOR CULTURING GENETICALLY MODIFIED HOST CELLSJul 3, 2025 · Application 18869250Pending
- Production Of IsoprenoidsApr 17, 2025 · Application 18915097Pending
- Pisum Sativum Kaurene Oxidase For High Efficiency Production Of RebaudiosidesApr 1, 2025 · US 12,264,351Granted
- Stevia Rebaudiana Kaurenoic Acid Hydroxylase Variants For High Efficiency Production Of RebaudiosidesFeb 11, 2025 · US 12,221,641Granted
- Olefins And Methods For Making The SameFeb 6, 2025 · Application 18906619Pending
- Methods For Genomic Integration For Kluyveromyces Host CellsJan 7, 2025 · US 12,188,044Granted
- Olefins And Methods For Making The SameJan 7, 2025 · US 12,187,674Granted
- High Efficiency Production Of Cannabigerolic Acid And Cannabidiolic AcidJan 2, 2025 · Application 18578903Pending
- Compositions And Methods For Skin Barrier Improvement And Irritation ReductionDec 26, 2024 · Application 18336533Pending
- Methods For Genomic Integration In Pichia And Other Host CellsDec 17, 2024 · US 12,168,769Granted
- Methods Of Producing Human Milk Oligosaccharides And Compositions ThereofNov 21, 2024 · Application 18688617Pending
- Production Of IsoprenoidsNov 19, 2024 · US 12,146,176Granted
- Methods Of Purifying CannabinoidsNov 7, 2024 · Application 18566902Pending
Related companies, and why
- FOX CHASE CHEMICAL DIVERSITY CENTER INC.Similar federal contract value in Biotech · $307K in contracts
- VENTRIA BIOSCIENCESimilar federal contract value in Biotech · $305K in contracts
- MIRECULE INCSimilar federal contract value in Biotech · $305K in contracts
- Oncotab, Inc.Similar federal contract value in Biotech · $300K in contracts
- Delphi Genomics, LLCSimilar federal contract value in Biotech · $300K in contracts
- GENECURE LLCSimilar federal contract value in Biotech · $300K in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .